The derivative product from the Tetramatrix™ platform technology is applied via direct injection at the site to generate a matrix structure and create space between the prostate and the surrounding tissues. No additional preparation is required and the product is provided in single syringe format for the ease of clinical application. The biomimetic properties of the product derived from the Tetramatrix™ platform technology result in minimal foreign body reactions, and therefore reduces the risk associated with encapsulation and fibrotic tissue formation around implants.

Upon application, due to the chemistry of the product, the Tutelix solution moulds with itself, forming a single cohesive structure. There is no polymerisation reaction involved in the gelation process, therefore the product is amenable to both slow and fast insertion. During injection and after gelation, the product remains visible under ultrasound, allowing its simple clinical application at the point of care.

By implementing a simple chemical adjustment in the core technology, the product derived from the Tetramatrix™ platform technology is visible under ultrasound imaging, allowing easy placement of the implant at the intended site. The formation of a matrix structure at the site generates space between the prostate and the surrounding tissue. The product has similar visibility under CT-scan to that of bone, without affecting the radiation dose. The formed matrix structure allows for clear delineation of the product between the rectal wall and prostate tissue, providing physicians confidence in targeting which minimises the risk of rectal perforation.

The product derived from the Tetramatrix™ platform technology forms a cohesive structure that can be “topped up” by multiple injections to increase the volume or to adjust the shape. The resulting matrix structure maintains favourable visibility with different medical imaging techniques. The formed matrix displays structural stability for at least 12 weeks after injection and gradually resorbs.